These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21853640)

  • 1. Toward better COPD management: practical aspects of inhaler use.
    Garvey C; Ortiz G; Yawn BP
    Adv NPs PAs; 2011 Aug; 2(8):27-30, 32. PubMed ID: 21853640
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological management--inhaled treatment.
    Currie GP; Lipworth BJ
    BMJ; 2006 Jun; 332(7555):1439-41. PubMed ID: 16777889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Triple fix-dose combination for treatment of COPD: convenient and effective].
    Worth H; Criée CP
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1668. PubMed ID: 27855451
    [No Abstract]   [Full Text] [Related]  

  • 6. Nebulized respiratory medications: friend or foe?
    Zarowitz BJ
    Geriatr Nurs; 2009; 30(1):45-9. PubMed ID: 19215812
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indacaterol (Onbrez Breezhaler), oral inhalation].
    Duh D; Tanret I
    J Pharm Belg; 2011 Dec; (4):127-8. PubMed ID: 22299240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Not Available].
    Raphaël B; Fumeaux T
    Rev Med Suisse; 2016 Oct; 12(533):1684. PubMed ID: 28686388
    [No Abstract]   [Full Text] [Related]  

  • 10. COPD drugs: the urgent need for innovation.
    Vestbo J; Lange P
    Lancet Respir Med; 2014 Jan; 2(1):14-5. PubMed ID: 24461887
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of bronchodilators.
    Booker R
    Nurs Times; 2004 Feb 10-16; 100(6):54-7, 59. PubMed ID: 15000031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiriva (Respimat) increases mortality by 52% in patients with COPD: time to take action.
    Ram FS
    N Z Med J; 2011 Jun; 124(1337):117-8. PubMed ID: 21946887
    [No Abstract]   [Full Text] [Related]  

  • 13. Are beta2-agonists safe in patients with acute exacerbations of COPD?
    Joos GF
    Am J Respir Crit Care Med; 2007 Aug; 176(4):322-3. PubMed ID: 17675449
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of combining inhaled drugs for COPD.
    Bjerg A; Lundbäck B; Lötvall J
    Curr Opin Pharmacol; 2012 Jun; 12(3):252-5. PubMed ID: 22465638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled drugs as risk factors for community-acquired pneumonia.
    Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
    Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indacterol (Arcapta Neohaler) for COPD.
    Med Lett Drugs Ther; 2012 Apr; 54(1389):33-5. PubMed ID: 22538621
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD.
    Jones LH; Baldock H; Bunnage ME; Burrows J; Clarke N; Coghlan M; Entwistle D; Fairman D; Feeder N; Fulton C; Hilton L; James K; Jones RM; Kenyon AS; Marshall S; Newman SD; Osborne R; Patel S; Selby MD; Stuart EF; Trevethick MA; Wright KN; Price DA
    Bioorg Med Chem Lett; 2011 May; 21(9):2759-63. PubMed ID: 21075627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary disease.
    Puig A; McElligott S; Bergquist H; Doshi JA
    Am J Geriatr Pharmacother; 2010 Dec; 8(6):571-82. PubMed ID: 21356506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
    Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P
    Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.